These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8541124)

  • 1. Salvage chemotherapy in non-dysgerminomatous germ cell tumours of the ovary.
    Culine S; Lhomme C; Farhat F; Droz JP
    Eur J Cancer; 1995 Oct; 31A(11):1890-1. PubMed ID: 8541124
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of a risk stratification system to guide treatment for female germ cell tumors.
    Meisel JL; Woo KM; Sudarsan N; Eng J; Patil S; Jacobsen EP; Murali R; Gardner GJ; Bosl GJ; Aghajanian C; Feldman DR
    Gynecol Oncol; 2015 Sep; 138(3):566-72. PubMed ID: 26115974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced germ cell malignancies of the ovary: should neo-adjuvant chemotherapy be the first line of treatment?
    Raveendran A; Gupta S; Bagga R; Saha SC; Gainder S; Dhaliwal LK; Patel F; Dey P; Nijhawan R
    J Obstet Gynaecol; 2010 Jan; 30(1):53-5. PubMed ID: 20121506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Management in advanced germ-cell tumors--report of two cases].
    Ismail E; Kornovski Y
    Akush Ginekol (Sofiia); 2015; 54(1):27-31. PubMed ID: 25909127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy in management of mixed mesodermal tumors of the ovary.
    Lele SB; Piver MS; Barlow JJ
    Gynecol Oncol; 1980 Dec; 10(3):298-302. PubMed ID: 6257596
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chemotherapy for ovarian malignant germ cell tumors].
    Nagai Y; Inamine M; Kudaka W; Aoki Y
    Nihon Rinsho; 2012 Jun; 70 Suppl 4():648-55. PubMed ID: 23156326
    [No Abstract]   [Full Text] [Related]  

  • 7. Surgery is an essential part of salvage treatment in refractory germ cell tumors.
    Albers P
    Eur Urol; 2006 Nov; 50(5):893-4. PubMed ID: 16753254
    [No Abstract]   [Full Text] [Related]  

  • 8. [Tumors of ovary and testis (author's transl)].
    De Jager R
    Rev Med Brux; 1980 May; 1(5):315-20. PubMed ID: 6258206
    [No Abstract]   [Full Text] [Related]  

  • 9. Salvage chemotherapy for refractory germ cell tumors.
    Dorff TB; Hu JS; Quinn DI
    Oncology (Williston Park); 2014 Jun; 28(6):498-500. PubMed ID: 25134324
    [No Abstract]   [Full Text] [Related]  

  • 10. [Malignant ovarian germ cell tumours: a trial of 36 cases].
    Gueye A; Narducci F; Baranzelli MC; Collinet P; Farine O; Fournier C; Vinatier D; Leblanc E
    Gynecol Obstet Fertil; 2007 May; 35(5):406-19. PubMed ID: 17350873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial comment to Salvage combined chemotherapy with paclitaxel, ifosfamide and nedaplatin for patients with advanced germ cell tumors.
    Miyake H; Fujisawa M
    Int J Urol; 2015 Mar; 22(3):293. PubMed ID: 25422037
    [No Abstract]   [Full Text] [Related]  

  • 12. Ovarian malignant mixed mesodermal tumor response to cis-diamminedichloroplatinum.
    Graciansky AM; Jenison EL
    Eur J Gynaecol Oncol; 1989; 10(5):296-9. PubMed ID: 2553413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of post-chemotherapy surgery for residual disease in ovarian germ cell tumors.
    Naik R
    J Postgrad Med; 2006; 52(4):245-6. PubMed ID: 17191355
    [No Abstract]   [Full Text] [Related]  

  • 14. [Update on malignant nonepithelial ovarian tumours].
    Bats AS; Larousserie F; Le Frère Belda MA; Metzger U; Lécuru F
    Gynecol Obstet Fertil; 2009; 37(7-8):627-32. PubMed ID: 19574079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germ cell malignancies of the ovary: treatment with vinblastine, actinomycin D, bleomycin and cisplatin containing chemotherapy combinations.
    Bradof JE; Hakes TB; Ochoa M; Golbey R
    Cancer; 1982 Sep; 50(6):1070-5. PubMed ID: 6179591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re: First salvage treatment in patients with advanced germ cell cancer after cisplatin-based chemotherapy: analysis of a registry of the German Testicular Cancer Study Group (GTCSG).
    Richie JP
    J Urol; 2015 Mar; 193(3):850. PubMed ID: 25765390
    [No Abstract]   [Full Text] [Related]  

  • 17. [The modern management of malignant germ cell tumor of the ovary].
    Anteby SO; Samuelof A; Biran S
    Harefuah; 1987 Feb; 112(3):132-5. PubMed ID: 3038713
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ovarian malignant tumours. Efficacy of germ cell and sex cord tumour treatment protocol in Poland].
    Popadiuk S; Korzon M; Chybicka A; Szmyd K; Dzierzega M; Trelińska J; Kowalczyk JR; Wiśniewska-Slusarz H; Woźniak W; Bilska K; Wachowiak J; Konatkowska B; Wysocki M; Krawczuk-Rybak M; Czauderna P; Szumera M; Sznurkowska K; Renke J
    Med Wieku Rozwoj; 2006; 10(3 Pt 1):803-10. PubMed ID: 17317911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors and role of salvage surgery in chemorefractory ovarian germ cell malignancies: a study in Chinese patients.
    Li J; Yang W; Wu X
    Gynecol Oncol; 2007 Jun; 105(3):769-75. PubMed ID: 17459461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results of two VAB-like regimens (vinblastine + actinomycin-D + bleomycin + cyclophosphamide + cisplatin) in malignant germ cell tumours of the ovary.
    Culine S; Lhomme C; Kattan J; Duvillard P; Michel G; Droz JP
    Eur J Cancer; 1994; 30A(9):1239-44. PubMed ID: 7528029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.